Association between piperacillin/tazobactam use and acute kidney injury in critically ill patients: a retrospective multicentre cohort study.
Bruno Martins TomaziniBruno Adler Maccagnan Pinheiro BesenLeandro Utino TaniguchiFernando Godinho ZampieriAlexandre Biasi CavalcantiPublished in: The Journal of antimicrobial chemotherapy (2024)
In critically ill patients, exposure to piperacillin/tazobactam was associated with increased risk of AKI and with increased risk of RRT, regardless of combination therapy with vancomycin.